Anan Raghunath

Summary

Country: UK

Publications

  1. ncbi Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review
    Anan Raghunath
    Centre for Integrated Health Care Research, Wolfson Research Institute, University of Durham, Stockton on Tees TS17 6BH
    BMJ 326:737. 2003
  2. ncbi Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors
    A S Raghunath
    School of Medicine and Health, Durham University, Wolfson Research Institute, University Boulevard, Stockton on Tees, UK
    Aliment Pharmacol Ther 29:431-9. 2009
  3. ncbi Helicobacter pylori eradication in long-term proton pump inhibitor users in primary care: a randomized controlled trial
    A S Raghunath
    School for Health, University of Durham, Queen s Campus, Wolfson Research Unit, University Boulevard, Stockton on Tees, UK
    Aliment Pharmacol Ther 25:585-92. 2007
  4. ncbi Difficulties in the interpretation of lung function tests in the diagnosis of asthma and chronic obstructive pulmonary disease
    Anan S Raghunath
    Academic Department of Primary Care and Public Health, University of Hull, United Kingdom
    J Asthma 43:657-60. 2006
  5. ncbi Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis
    A S Raghunath
    Centre for Integrated Health Care Research, Wolfson Research Institute, University of Durham, Queen s Campus, Stockton on Tees, UK
    Aliment Pharmacol Ther 20:733-44. 2004
  6. ncbi Use of proton pump inhibitors: an exploration of the attitudes, knowledge and perceptions of general practitioners
    A S Raghunath
    School for Health, University of Durham, Queen s Campus, Wolfson Research Institute, Stockton on Tees, UK
    Digestion 72:212-8. 2005
  7. ncbi Review article: the long-term use of proton-pump inhibitors
    A S Raghunath
    Centre for Integrated Health Care Research, Wolfson Research Institute, University of Durham, Stockton on Tees, UK
    Aliment Pharmacol Ther 22:55-63. 2005
  8. ncbi Managing gastro-oesophageal reflux disease in the older patient
    A Pali S Hungin
    Centre for Integrated Health Care Research, Wolfson Research Institute, University of Durham, UK
    Digestion 69:17-24. 2004
  9. ncbi Systematic review: Patterns of proton pump inhibitor use and adherence in gastroesophageal reflux disease
    A Pali S Hungin
    School of Medicine and Health, Wolfson Research Institute, Durham University, Stockton on Tees, United Kingdom
    Clin Gastroenterol Hepatol 10:109-16. 2012
  10. ncbi Gastro-oesophageal reflux disease
    Anan S Raghunath
    Hull York Medical School, Marmaduke Health Centre, Hull
    Prof Nurse 19:371-2. 2004

Detail Information

Publications13

  1. ncbi Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review
    Anan Raghunath
    Centre for Integrated Health Care Research, Wolfson Research Institute, University of Durham, Stockton on Tees TS17 6BH
    BMJ 326:737. 2003
    ..To ascertain the prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease and its association with the disease...
  2. ncbi Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors
    A S Raghunath
    School of Medicine and Health, Durham University, Wolfson Research Institute, University Boulevard, Stockton on Tees, UK
    Aliment Pharmacol Ther 29:431-9. 2009
    ..Symptom control in primary care patients on long-term proton pump inhibitor (PPI) treatment is poorly understood...
  3. ncbi Helicobacter pylori eradication in long-term proton pump inhibitor users in primary care: a randomized controlled trial
    A S Raghunath
    School for Health, University of Durham, Queen s Campus, Wolfson Research Unit, University Boulevard, Stockton on Tees, UK
    Aliment Pharmacol Ther 25:585-92. 2007
    ..Two-thirds of proton pump inhibitor prescribing in the UK is for long-term therapy...
  4. ncbi Difficulties in the interpretation of lung function tests in the diagnosis of asthma and chronic obstructive pulmonary disease
    Anan S Raghunath
    Academic Department of Primary Care and Public Health, University of Hull, United Kingdom
    J Asthma 43:657-60. 2006
    ....
  5. ncbi Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis
    A S Raghunath
    Centre for Integrated Health Care Research, Wolfson Research Institute, University of Durham, Queen s Campus, Stockton on Tees, UK
    Aliment Pharmacol Ther 20:733-44. 2004
    ..Recent guidelines recommend H. pylori eradication in patients on long-term proton pump inhibitors...
  6. ncbi Use of proton pump inhibitors: an exploration of the attitudes, knowledge and perceptions of general practitioners
    A S Raghunath
    School for Health, University of Durham, Queen s Campus, Wolfson Research Institute, Stockton on Tees, UK
    Digestion 72:212-8. 2005
    ..The aim of this study is therefore to investigate how GPs make decisions about PPI prescribing...
  7. ncbi Review article: the long-term use of proton-pump inhibitors
    A S Raghunath
    Centre for Integrated Health Care Research, Wolfson Research Institute, University of Durham, Stockton on Tees, UK
    Aliment Pharmacol Ther 22:55-63. 2005
    ..Overall, on-demand therapy is more cost-effective than continuous therapy and should be considered wherever possible...
  8. ncbi Managing gastro-oesophageal reflux disease in the older patient
    A Pali S Hungin
    Centre for Integrated Health Care Research, Wolfson Research Institute, University of Durham, UK
    Digestion 69:17-24. 2004
    ....
  9. ncbi Systematic review: Patterns of proton pump inhibitor use and adherence in gastroesophageal reflux disease
    A Pali S Hungin
    School of Medicine and Health, Wolfson Research Institute, Durham University, Stockton on Tees, United Kingdom
    Clin Gastroenterol Hepatol 10:109-16. 2012
    ..This review aimed to systematically investigate the literature on patterns of PPI use in patients with gastroesophageal reflux disease (GERD)...
  10. ncbi Gastro-oesophageal reflux disease
    Anan S Raghunath
    Hull York Medical School, Marmaduke Health Centre, Hull
    Prof Nurse 19:371-2. 2004
    ..Part two of this article on GORD examines investigations and treatment options once the initial diagnosis of the condition has been made and focuses on the role that nurses can play in helping patients with this condition...
  11. ncbi A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis
    Anan S Raghunath
    St. Andrews Group Practice, Hull, Luton, United Kingdom
    Clin Ther 25:2088-101. 2003
    ..CONCLUSION: The currently available comparative data for esomeprazole and lansoprazole indicate clinical and cost-effectiveness advantages for esomeprazole in the healing and maintenance of erosive esophagitis compared with lansoprazole...
  12. ncbi Beyond heartburn: a systematic review of the extra-oesophageal spectrum of reflux-induced disease
    A Pali S Hungin
    Cetre for Integrated Health Care Research, University of Durham Stockton Campus, Wolfson Research Institute, Stockton on Tees TS176BH, UK
    Fam Pract 22:591-603. 2005
    ..GORD is characterized by heartburn and acid regurgitation, but is reported to be associated with a spectrum of extra-oesophageal symptoms...
  13. ncbi GORD: Part 1. Gastro-oesophageal reflux disease
    Anan S Raghunath
    Hull York Medical School, St Andrews Group Practice, Marmaduke Health Centre, Hull
    Prof Nurse 19:315-6. 2004